Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients.
D'Incecco A, Andreozzi M, Ludovini V, Rossi E, Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J, Coppi E, Chella A, Fontanini G, Filice ME, Tornillo L, Incensati RM, Sani S, Crinò L, Terracciano L, Cappuzzo F. D'Incecco A, et al. Br J Cancer. 2015 Jan 6;112(1):95-102. doi: 10.1038/bjc.2014.555. Epub 2014 Oct 28. Br J Cancer. 2015. PMID: 25349974 Free PMC article.
Gefitinib for non-small-cell lung cancer treatment.
D'Incecco A, Cappuzzo F. D'Incecco A, et al. Expert Opin Drug Saf. 2011 Nov;10(6):987-96. doi: 10.1517/14740338.2011.617738. Epub 2011 Sep 12. Expert Opin Drug Saf. 2011. PMID: 21905963 Review.
Rare mutations in non-small-cell lung cancer.
D'Arcangelo M, D'Incecco A, Cappuzzo F. D'Arcangelo M, et al. Future Oncol. 2013 May;9(5):699-711. doi: 10.2217/fon.13.16. Future Oncol. 2013. PMID: 23647298 Review.
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.
Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM. Gasparini P, et al. Among authors: d incecco a. Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14924-9. doi: 10.1073/pnas.1520329112. Epub 2015 Nov 16. Proc Natl Acad Sci U S A. 2015. PMID: 26627242 Free PMC article.
First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly 'unfrail' patients with advanced non-small-cell lung cancer: a multicenter phase II study.
Tibaldi C, Camerini A, D'Incecco A, Vasile E, Fabbri A, Amoroso D, Cappuzzo F. Tibaldi C, et al. J Cancer Res Clin Oncol. 2012 Dec;138(12):2003-8. doi: 10.1007/s00432-012-1280-5. Epub 2012 Jul 6. J Cancer Res Clin Oncol. 2012. PMID: 22767317 Clinical Trial.
Targeted therapy for NSCLC with driver mutations.
Minuti G, D'Incecco A, Cappuzzo F. Minuti G, et al. Expert Opin Biol Ther. 2013 Oct;13(10):1401-12. doi: 10.1517/14712598.2013.827657. Epub 2013 Aug 10. Expert Opin Biol Ther. 2013. PMID: 23930754 Review.
36 results